Anti-CBLN3/ PRO1486 functional antibody

Anti-CBLN3/ PRO1486 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CBLN3/CBLN3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0733-Ab-1/ GM-Tg-hg-SE0733-Ab-2Anti-Human CBLN3 monoclonal antibodyHuman
GM-Tg-rg-SE0733-Ab-1/ GM-Tg-rg-SE0733-Ab-2Anti-Rat CBLN3 monoclonal antibodyRat
GM-Tg-mg-SE0733-Ab-1/ GM-Tg-mg-SE0733-Ab-2Anti-Mouse CBLN3 monoclonal antibodyMouse
GM-Tg-cynog-SE0733-Ab-1/ GM-Tg-cynog-SE0733-Ab-2Anti-Cynomolgus/ Rhesus macaque CBLN3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0733-Ab-1/ GM-Tg-felg-SE0733-Ab-2Anti-Feline CBLN3 monoclonal antibodyFeline
GM-Tg-cang-SE0733-Ab-1/ GM-Tg-cang-SE0733-Ab-2Anti-Canine CBLN3 monoclonal antibodyCanine
GM-Tg-bovg-SE0733-Ab-1/ GM-Tg-bovg-SE0733-Ab-2Anti-Bovine CBLN3 monoclonal antibodyBovine
GM-Tg-equg-SE0733-Ab-1/ GM-Tg-equg-SE0733-Ab-2Anti-Equine CBLN3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0733-Ab-1/ GM-Tg-hg-SE0733-Ab-2; GM-Tg-rg-SE0733-Ab-1/ GM-Tg-rg-SE0733-Ab-2;
GM-Tg-mg-SE0733-Ab-1/ GM-Tg-mg-SE0733-Ab-2; GM-Tg-cynog-SE0733-Ab-1/ GM-Tg-cynog-SE0733-Ab-2;
GM-Tg-felg-SE0733-Ab-1/ GM-Tg-felg-SE0733-Ab-2; GM-Tg-cang-SE0733-Ab-1/ GM-Tg-cang-SE0733-Ab-2;
GM-Tg-bovg-SE0733-Ab-1/ GM-Tg-bovg-SE0733-Ab-2; GM-Tg-equg-SE0733-Ab-1/ GM-Tg-equg-SE0733-Ab-2
Products NameAnti-CBLN3 monoclonal antibody
Formatmab
Target NameCBLN3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CBLN3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0733-Ag-1Recombinant multi-species CBLN3/ PRO1486 protein


    Target information

    Target IDGM-SE0733
    Target NameCBLN3
    Gene ID643866,56410,501998,716357,490626,101084032,529166,100054062
    Gene Symbol and SynonymsCBLN3,PRO1486,RGD1563731
    Uniprot AccessionQ6UW01,Q17QF9
    Uniprot Entry NameCBLN3_HUMAN,CBLN3_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000139899
    Target ClassificationN/A

    The target: CBLN3, gene name: CBLN3, also named as PRO1486. Members of the precerebellin family, such as CBLN3, contain a cerebellin motif (see CBLN1; MIM 600432) and a C-terminal C1q signature domain (see MIM 120550) that mediates trimeric assembly of atypical collagen complexes. However, precerebellins do not contain a collagen motif, suggesting that they are not conventional components of the extracellular matrix (Pang et al., 2000 [PubMed 10964938]).[supplied by OMIM, Aug 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.